[HTML][HTML] Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic …
CQ Huang, Y Min, SY Wang, XJ Yang, Y Liu, B Xiong… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II …
CQ Huang, XJ Yang, Y Yu, HT Wu, Y Liu… - PLOS …, 2014 - journals.plos.org
Background Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal
cancer (CRC) because conventional treatment modalities could not produce significant …
cancer (CRC) because conventional treatment modalities could not produce significant …
Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis
GA Simkens, TR van Oudheusden, MD Luyer… - Annals of surgical …, 2015 - Springer
Background The prognosis of patients with peritoneally metastasized colorectal cancer has
improved significantly with the introduction of cytoreductive surgery followed by …
improved significantly with the introduction of cytoreductive surgery followed by …
Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis
GA Simkens, TR van Oudheusden, MD Luyer… - Annals of surgical …, 2016 - Springer
Background Severe morbidity after cytoreductive surgery (CRS) followed by hyperthermic
intraperitoneal chemotherapy (HIPEC) is, besides the obvious short-term consequences …
intraperitoneal chemotherapy (HIPEC) is, besides the obvious short-term consequences …
[HTML][HTML] Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
HAH al-Shammaa, Y Li, Y Yonemura - World journal of …, 2008 - ncbi.nlm.nih.gov
This article is to offer a concise review on the use of cytoreductive surgery (CRS) plus
intraperitoneal hyperthermic chemotherapy (IPHC) for the treatment of peritoneal …
intraperitoneal hyperthermic chemotherapy (IPHC) for the treatment of peritoneal …
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy …
D Hompes, A D'Hoore, E Van Cutsem, S Fieuws… - Annals of surgical …, 2012 - Springer
Background Up to 25% of patients with metastatic colorectal cancer (CRC) present with
peritoneal carcinomatosis (PC) as the only site of metastases. Complete cytoreductive …
peritoneal carcinomatosis (PC) as the only site of metastases. Complete cytoreductive …
Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer …
M Maillet, O Glehen, J Lambert, D Goere… - Annals of surgical …, 2016 - Springer
Purpose The prognosis of peritoneal carcinomatosis (PC) from colorectal cancer has been
improved with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy …
improved with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy …
A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin
C Cao, TD Yan, D Black, DL Morris - Annals of surgical oncology, 2009 - Springer
Background The objective of the present meta-analysis was to analyze the survival
outcomes of patients with colorectal peritoneal carcinomatosis (CRPC), with particular focus …
outcomes of patients with colorectal peritoneal carcinomatosis (CRPC), with particular focus …
Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of …
HJ Braam, TR Van Oudheusden… - Journal of surgical …, 2014 - Wiley Online Library
Abstract Background and Objectives CytoReductive Surgery (CRS) combined with
Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) has an established role in the …
Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) has an established role in the …
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer
MK Gervais, P Dubé, Y McConnell… - Journal of Surgical …, 2013 - Wiley Online Library
Background Peritoneal carcinomatosis (PC) from colorectal cancer is associated with a poor
prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy …
prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy …
相关搜索
- cytoreductive surgery peritoneal carcinomatosis
- colorectal cancer peritoneal carcinomatosis
- colorectal cancer cytoreductive surgery
- meta analysis peritoneal carcinomatosis
- meta analysis cytoreductive surgery
- colorectal cancer meta analysis
- survival for patients cytoreductive surgery
- colorectal cancer survival for patients
- survival for patients peritoneal carcinomatosis
- peroperative chemotherapy peritoneal carcinomatosis
- colorectal cancer peroperative chemotherapy
- cytoreductive surgery severe morbidity
- chinese center peritoneal carcinomatosis
- patterns of recurrence peritoneal carcinomatosis
- cytoreductive surgery chinese center
- cytoreductive surgery early recurrence